Brokerages forecast that National Health Investors Inc (NYSE:NHI) will post $1.39 earnings per share for the current quarter, according to Zacks. Three analysts have made estimates for National Health Investors’ earnings, with the lowest EPS estimate coming in at $1.38 and the highest estimate coming in at $1.41. National Health Investors reported earnings of $1.37 per share in the same quarter last year, which would indicate a positive year over year growth rate of 1.5%. The company is expected to issue its next earnings results before the market opens on Tuesday, November 6th.

According to Zacks, analysts expect that National Health Investors will report full-year earnings of $5.51 per share for the current year, with EPS estimates ranging from $5.50 to $5.53. For the next financial year, analysts expect that the firm will post earnings of $5.68 per share, with EPS estimates ranging from $5.62 to $5.83. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that that provide coverage for National Health Investors.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Tuesday, August 7th. The real estate investment trust reported $0.91 EPS for the quarter, missing the consensus estimate of $0.96 by ($0.05). The firm had revenue of $72.96 million for the quarter, compared to analysts’ expectations of $73.80 million. National Health Investors had a net margin of 53.16% and a return on equity of 11.49%.

Several brokerages have recently commented on NHI. Wells Fargo & Co restated a “hold” rating on shares of National Health Investors in a research note on Tuesday, August 28th. SunTrust Banks restated a “hold” rating and set a $79.00 price target on shares of National Health Investors in a research note on Wednesday, August 8th. They noted that the move was a valuation call. Stifel Nicolaus set a $83.00 price objective on National Health Investors and gave the company a “buy” rating in a research report on Tuesday, August 7th. Cantor Fitzgerald raised their price objective on National Health Investors from $75.00 to $80.00 and gave the company a “neutral” rating in a research report on Wednesday, August 8th. Finally, Zacks Investment Research downgraded National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, August 14th. One analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $75.22.

Hedge funds and other institutional investors have recently modified their holdings of the business. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in National Health Investors by 35.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,926 shares of the real estate investment trust’s stock worth $1,173,000 after acquiring an additional 4,144 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in National Health Investors by 7.6% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 42,521 shares of the real estate investment trust’s stock worth $3,133,000 after acquiring an additional 2,987 shares in the last quarter. First Trust Advisors LP raised its stake in shares of National Health Investors by 26.2% in the second quarter. First Trust Advisors LP now owns 82,106 shares of the real estate investment trust’s stock worth $6,050,000 after purchasing an additional 17,059 shares during the last quarter. Macquarie Group Ltd. raised its stake in shares of National Health Investors by 15.5% in the second quarter. Macquarie Group Ltd. now owns 13,400 shares of the real estate investment trust’s stock worth $987,000 after purchasing an additional 1,800 shares during the last quarter. Finally, Paloma Partners Management Co purchased a new position in shares of National Health Investors in the second quarter worth about $566,000. 68.55% of the stock is owned by institutional investors and hedge funds.

Shares of National Health Investors stock traded down $1.55 during trading on Friday, hitting $72.72. 207,541 shares of the stock traded hands, compared to its average volume of 173,696. The firm has a market cap of $3.07 billion, a P/E ratio of 13.64, a P/E/G ratio of 3.11 and a beta of 0.34. The company has a current ratio of 15.56, a quick ratio of 15.56 and a debt-to-equity ratio of 0.90. National Health Investors has a 52-week low of $62.71 and a 52-week high of $81.60.

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 9th. Shareholders of record on Friday, September 28th will be issued a $1.00 dividend. This represents a $4.00 annualized dividend and a yield of 5.50%. The ex-dividend date of this dividend is Thursday, September 27th. National Health Investors’s dividend payout ratio is presently 75.05%.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Further Reading: What is a Call Option?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.